Single-cell immune landscape of the central nervous system of mice infected with rabies virus - Report - MDSpire

Single-cell immune landscape of the central nervous system of mice infected with rabies virus

  • By

  • Xinyue Wang

  • Xinjie Zhang

  • Wenwen He

  • Xianzhu Xia

  • Pingsen Zhao

  • July 2, 2026

  • 0 min

Share

Characterization of the Immune Cell Composition in the CNS of Rabies-Infected Mice

Overview

This study provides a detailed analysis of immune responses in the central nervous system (CNS) of mice infected with virulent and attenuated rabies virus strains. Using single-cell RNA sequencing, distinct immune cell profiles were identified.

Background

Rabies virus (RABV) infection leads to nearly 100% mortality once neurological symptoms appear, making it a critical public health concern. Understanding the immune response in the CNS during RABV infection is essential. This study aims to elucidate the cellular and molecular dynamics that differentiate outcomes of infections with virulent and attenuated RABV strains.

Data Highlights

Single-cell RNA sequencing was performed on over 100,000 cells from the brains of CVS-11 infected, SRV9 infected, and mock infected mice.

Key Findings

  • CVS-11 infection was associated with a phagocytic microglial signature and excessive neutrophilic inflammation.
  • SRV9 infection correlated with an immunoregulatory microglial phenotype and effective NK cell antiviral function.
  • Downregulation of NK cell functional genes was observed in CVS-11 infection, indicating potential dysfunction.
  • Increased expression of T cell exhaustion-related genes was noted in CVS-11 infection.
  • Distinct transcriptional signatures were identified, suggesting different immune mechanisms between virulent and attenuated strains.
  • A set of signature genes (Fkbp5, Apod, Klf2, Socs3) was linked to lethal RABV infection outcomes.

Clinical Implications

The findings from this study highlight the immune mechanisms associated with different outcomes of rabies virus infections.

Conclusion

This research enhances the understanding of immune responses in the CNS during rabies virus infection, revealing differences between virulent and attenuated strains.

Related Resources & Content

  1. CDC, Rabies, 2025 -- Rabies Post-exposure Prophylaxis Guidance
  2. BMC Infectious Diseases, 2025 -- A randomized, non-inferiority phase III clinical trial of immunogenicity and safety of 5-dose and 4-dose schedules of a freeze-dried human rabies vaccine
  3. Acta Neuropathologica, 2023 -- Sustained Presence of Virus-Specific and Clonally Expanded Antibody-Secreting Cells in Response to Induced Self-Antigen within the Central Nervous System
  4. Acta Neuropathologica, 2021 -- The Role of Microglia and Monocytes in CNS Inflammatory Disorders: A Focus on Their Phenotypic and Functional Integration
  5. Acta Neuropathologica, 2018 -- Microglial Regulation of Neurotropic Virus Propagation Through P2Y12 Signaling and Monocyte Recruitment via Alternative Pathways
  6. Acta Neuropathologica — Endogenous Type I Interferon Activation in the Central Nervous System Provides Protective Effects in Experimental Autoimmune Encephalomyelitis
  7. Rabies Post-exposure Prophylaxis Guidance | Rabies | CDC
  8. A randomized, non-inferiority phase III clinical trial of immunogenicity and safety of 5-dose and 4-dose schedules of a freeze-dried human rabies vaccine (MRC-5 cells) in participants aged 10–60 | BMC Infectious Diseases | Springer Nature Link
  9. www.nature.com/cmi

Original Source(s)

Related Content